Current status: 820 hESC lines, 2982 hiPSC lines, and 94 clinical studies, and 370 certificates
Monthly statistic from Jan 1, 2022
Posted on January 1, 2022
| total lines | 3802 |
| hESC lines | 820 |
| hiPSC lines | 2982 |
| derivation countries | 40 |
| projects | 211 |
| providers | 677 |
| clinical studies | 94 |
| subclones | 1407 |
| certificates | 370 |
| cell line certificates | 266 |
| project certificates | 104 |